Literature DB >> 543573

Field test and experimental use of CYBEST model 2 for practical gynecologic mass screening.

N Tanaka, H Ikeda, T Ueno, A Mukawa, K Kamitsuma.   

Abstract

CYBEST is an automated cytologic screening system for uterine cancer utilizing a pattern-recognition image-analysis system. The prototype was developed in 1972 following fundamental studies of feature extraction, feature evaluation using ambiguity differential functions and segmentation of cell and nuclear images. Model 2 was developed in 1974 with an improved mechanism and function. The parameters employed are nuclear size, nuclear optical density, N/C ratio and nuclear shape. The data of field tests using 220 samples containing three cases of dysplasia, 110 cases of carcinoma and 107 nonmalignant cases were as follows: two false-negative cases (1.8%), 13 false positives (12.1%) and one reject (0.9%). This system was experimentally tested for practical mass population screening with 1,829 cases including 17 atypical cases (four epidermoid carcinomas). The data were as follows: no false-negative cases and 581 false-positive cases (32.1%). Of the latter, 311 cases (17.2%) were pathologic samples, such as severe cervicitis, senile colpitis, Trichomonas infestation, etc., and the remaining 270 cases (14.9%) were within physiologic limits, corresponding to true false-positive samples.

Entities:  

Mesh:

Year:  1979        PMID: 543573

Source DB:  PubMed          Journal:  Anal Quant Cytol        ISSN: 0190-0471


  2 in total

1.  Image analysis combined with quantitative cytochemistry. Results and instrumental developments for cancer diagnosis.

Authors:  J S Ploem; A M van Driel-Kulker; L Goyarts-Veldstra; J J Ploem-Zaaijer; N P Verwoerd; M van der Zwan
Journal:  Histochemistry       Date:  1986

2.  Tumor cell detection method using complement-mediated cytolytic reaction and imaging sensor system.

Authors:  M Suzuki; N Watanabe; E Tamiya; T Kataoka; T Tokunaga; I Karube
Journal:  Appl Biochem Biotechnol       Date:  1987-10       Impact factor: 2.926

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.